Baseline analysis of Mycoplasma mycoides subsp. mycoides antigens as targets for a DIVA assay for use with a subunit vaccine for contagious bovine pleuropneumonia.
Animals
Antibodies, Bacterial
/ blood
Antigens, Bacterial
/ immunology
Bacterial Vaccines
/ administration & dosage
Cattle
Cattle Diseases
/ diagnosis
Enzyme-Linked Immunosorbent Assay
/ veterinary
Male
Mycoplasma
/ immunology
Pleuropneumonia, Contagious
/ diagnosis
Vaccines, Subunit
/ administration & dosage
Antigens
CBPP
Cattle
DIVA
Mycoplasma mycoides
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
10 Jul 2020
10 Jul 2020
Historique:
received:
27
02
2020
accepted:
02
07
2020
entrez:
12
7
2020
pubmed:
12
7
2020
medline:
9
3
2021
Statut:
epublish
Résumé
Mycoplasma mycoides subsp. mycoides (Mmm) is the causative agent of contagious bovine pleuropneumonia in cattle. A prototype subunit vaccine is being developed, however, there is currently no diagnostic test that can differentiate between infected cattle and those vaccinated with the prototype subunit vaccine. This study characterized Mmm proteins to identify potential antigens for use in differentiating infected from vaccinated animals. Ten Mmm antigens expressed as recombinant proteins were tested in an indirect ELISA using experimental sera from control groups, infected, and vaccinated animals. Data were imported into R software for analysis and drawing of the box and scatter plots while Cohen's Kappa assessed the level of agreement between the Mmm antigens. Two vaccine antigens (MSC_0499 and MSC_0776) were superior in detecting antibodies in sera of animals vaccinated with the subunit vaccines while two non-vaccine antigens (MSC_0636 and LppB) detected antibodies in sera of infected animals showing all clinical stages of the disease. Sensitivity and specificity of above 87.5% were achieved when the MSC_0499 and MSC_0636 antigens were tested on sera from vaccinated and infected animals. The MSC_0499 and MSC_0776 antigens were the most promising for detecting vaccinated animals, while MSC_0636 and LppB were the best targets to identify infected animals. Further testing of sera from vaccinated and infected animals collected at different time intervals in the field should help establish how useful a diagnostic test based on a cocktail of these proteins would be.
Sections du résumé
BACKGROUND
BACKGROUND
Mycoplasma mycoides subsp. mycoides (Mmm) is the causative agent of contagious bovine pleuropneumonia in cattle. A prototype subunit vaccine is being developed, however, there is currently no diagnostic test that can differentiate between infected cattle and those vaccinated with the prototype subunit vaccine. This study characterized Mmm proteins to identify potential antigens for use in differentiating infected from vaccinated animals.
RESULTS
RESULTS
Ten Mmm antigens expressed as recombinant proteins were tested in an indirect ELISA using experimental sera from control groups, infected, and vaccinated animals. Data were imported into R software for analysis and drawing of the box and scatter plots while Cohen's Kappa assessed the level of agreement between the Mmm antigens. Two vaccine antigens (MSC_0499 and MSC_0776) were superior in detecting antibodies in sera of animals vaccinated with the subunit vaccines while two non-vaccine antigens (MSC_0636 and LppB) detected antibodies in sera of infected animals showing all clinical stages of the disease. Sensitivity and specificity of above 87.5% were achieved when the MSC_0499 and MSC_0636 antigens were tested on sera from vaccinated and infected animals.
CONCLUSIONS
CONCLUSIONS
The MSC_0499 and MSC_0776 antigens were the most promising for detecting vaccinated animals, while MSC_0636 and LppB were the best targets to identify infected animals. Further testing of sera from vaccinated and infected animals collected at different time intervals in the field should help establish how useful a diagnostic test based on a cocktail of these proteins would be.
Identifiants
pubmed: 32650780
doi: 10.1186/s12917-020-02453-w
pii: 10.1186/s12917-020-02453-w
pmc: PMC7350692
doi:
Substances chimiques
Antibodies, Bacterial
0
Antigens, Bacterial
0
Bacterial Vaccines
0
Vaccines, Subunit
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
236Subventions
Organisme : Canadian International Food Security Research Fund (CIFSRF); VACNADA; African Biosciences Challenge Fund
ID : 107849; DCI-FOOD/2009/226-469
Références
Vet Microbiol. 1998 Feb 28;60(2-4):179-91
pubmed: 9646449
Genome Res. 2004 Feb;14(2):221-7
pubmed: 14762060
Stand Genomic Sci. 2015 Oct 29;10:89
pubmed: 26516405
Vaccine. 2014 May 23;32(25):3107-14
pubmed: 24462404
Trop Anim Health Prod. 2012 Aug;44(6):1233-8
pubmed: 22528527
Vet Immunol Immunopathol. 2015 Nov 15;168(1-2):103-10
pubmed: 26384697
Microbiology. 2008 Feb;154(Pt 2):539-549
pubmed: 18227258
Vet Immunol Immunopathol. 2016 Oct 1;178:64-9
pubmed: 27496744
Vet Microbiol. 2010 May 19;142(3-4):285-92
pubmed: 19900769
Microbiology. 2008 Aug;154(Pt 8):2427-2436
pubmed: 18667575
Vet Immunol Immunopathol. 2016 Mar;171:103-14
pubmed: 26964722
Ann N Y Acad Sci. 2000;916:364-9
pubmed: 11193648
Rev Sci Tech. 1996 Dec;15(4):1331-53
pubmed: 9527412
Mem Inst Oswaldo Cruz. 2016 Jul 4;111(8):501-4
pubmed: 27384081
Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):227-38
pubmed: 17706775
Clin Diagn Lab Immunol. 2000 Jul;7(4):588-95
pubmed: 10882657
Res Vet Sci. 2006 Dec;81(3):304-9
pubmed: 16624356
J Microbiol Methods. 2010 Jun;81(3):211-8
pubmed: 20381545
Rev Sci Tech. 2006 Dec;25(3):999-1011
pubmed: 17361766
Int J Syst Evol Microbiol. 2009 Jun;59(Pt 6):1353-8
pubmed: 19502315
J Bacteriol. 2012 Aug;194(16):4448-9
pubmed: 22843585
Oncotarget. 2017 Nov 02;9(47):28322-28336
pubmed: 29983863
Vet Res. 2011 Jun 12;42:77
pubmed: 21663697
BMC Microbiol. 2009 Oct 09;9:215
pubmed: 19818124
BMC Vet Res. 2019 Dec 12;15(1):451
pubmed: 31831071
Vaccine. 2017 Dec 4;35(48 Pt B):6604-6610
pubmed: 29079106
Vet Immunol Immunopathol. 2018 Mar;197:7-14
pubmed: 29475510
Vet Microbiol. 2002 Jan 23;84(3):195-205
pubmed: 11731172
Clin Vaccine Immunol. 2009 Nov;16(11):1665-74
pubmed: 19726613
ILAR J. 2006;47(1):5-14
pubmed: 16391426
Comp Immunol Microbiol Infect Dis. 2010 Jul;33(4):279-90
pubmed: 19187963
J Clin Microbiol. 2016 Jun;54(6):1557-1565
pubmed: 27053669
Vet J. 2015 Jan;203(1):79-84
pubmed: 25467991
ILAR J. 2002;43(4):244-58
pubmed: 12391400
Vet Immunol Immunopathol. 2016 Jan;169:63-7
pubmed: 26827840